選択的BRAF阻害剤のポドサイト保護・毒性作用を決定付ける真の標的分子の同定

• Project/Area Number: 21K15319
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 47060:Clinical pharmacy-related
• Research Institution: Nagoya City University
• Principal Investigator: 真川 明将 名古屋市立大学, 薬学研究科(研究院), 助教 (20827670)
• Project Period (FY): 2021-04-01 – 2023-03-31
• Project Status: Adopted (Fiscal Year 2021)
• Budget Amount: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000); Fiscal Year 2022: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000); Fiscal Year 2021: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)